Nature does open access

Spoiler. It's actually Evusheld. Will definitely need to have some in depth discussions about benefits with any patients who ask for it...

Anyone able to access this full article? Can't seem to get the full text despite multiple different attempts...

Hanging out with the hospitalist

I'm happy to have this published! This is a forward looking review of current and potential therapies in CTCL with a focus on targeting the tumor microenvironment. I hope you will find it interesting and useful... authors.elsevier.com/a/1chU68THnW0g…

I feel bad for academics. You guys have to constantly come up with innovative ideas to advance medicine, meanwhile dudes in the 1800s were like “yo wash your hands” and became immediate professors at Harvard

.Adam Olszewski MD et al. NGS-MRD CSF assay detects CNS involvement in DLBCL not detected by conventional CSF methods. Small numbers in this proof of concept study but intriguing 100% sensitivity for CNS relapse. #lymsm #lymphoma #ASH20
ash.confex.com/ash/2020/webpr… 2/7

Ruan et al - CC486 (oral aza) + CHOP 1L PTCL
- 21 pts; 17 Tfh
- med 66y, 90% stage III/IV
- 10 had SCT
- No CHOP dose ⬇️
- EOT: 75% ORR & CRR (88% AITL)
- 1y PFS 66% (70% Tfh)
- TET2 MAY suggest better prog; DNMT worse
Small nos here - randomised trial coming.
#ASH20 #lymsm

Mehta Shah et al
huge dataset describing allogeneic stem cell transplantation in PTCL #ASH20
#lymSM
particularly encouraging data for hepatosplenic T-cell lymphoma